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Summary: This paper first seeks to evaluate current trends in methodology and technology and discusses possible
implications for the future of clinical chemistry, whose range and diversity of tasks are carefully defined. It is thought
that the remarkable development in the field of immunological methods, in the general sense of the word, will
continue for the years to come. One other principle, which it is predicted will play an increasing role, is thermometry
for the determination of enthalpy. Similarly, new developments in the fields of bio- and chemoluminescence offer
interesting possibilities. The impact of the computer in clinical chemistry is also discussed.
Secondly, the double role of clinical chemistry as a diagnostic speciality and as an academic field is analyzed. On the
one hand, the need for closer cooperation both with other diagnostic subspecialities and with other medical clinical
disciplines is stressed.
In particular, newly organized Departments of Laboratory Medicine encompassing microbiology, cytology, nuclear
medicine, toxicology etc. might contribute greatly to interdisciplinary understanding. On the other hand, problems
of clinical medicine and of certain areas within biological research should be at the center of interest of the future
research-oriented clinical chemist.
Entwicklungstendenzen in der Klinischen Chemie
Zusammenfassung: Einleitend wird über die sich wandelnden Definitionen des Faches „Klinische Chemie" referiert.
Die Erweiterung der Aufgabengebiete, die darin zum Ausdruck kommt, wird auch von den Entwicklungstendenzen
in methodischer und technologischer Hinsicht reflektiert.
Besonders auffallend ist die konstante Zunahme immunologischer Techniken und Methoden, die auch in der Routine-
analytik einen ständig wachsenden Anteil einnehmen. Zwei Meßprinzipien, die bisher noch wenig Anwendung in
der klinisch-chemischen Analytik finden, verdienen besonderes Interesse: Dies sind die Thermometrie zur Bestim-
mung der Enthalpie und die zahlreichen Verfahren, die auf Bio- und Chemo-Lumineszenz-Phänomenen beruhen.
Die aktuelle und zukünftige Bedeutung der elektronischen Datenverarbeitung in der klinischen Chemie wird kurz
diskutiert.
Manche Probleme im Selbstverständnis des klinischen Chemikers resultieren daraus, daß die klinische Chemie einer-
seits vielfältige diagnostische Dienstleistungen im Bereich der klinischen Medizin erbringen muß, andererseits aber
ein akademisches Grundlagenfach darstellt. Zur Überwindung vieler Schwierigkeiten wäre eine engere Kooperation
mit den anderen diagnostischen Fächern, aber auch mit den klinischen Disziplinen wünschenswert. Weiter dürfte es
von großem Vorteil sein, wenn es gelänge, die Abteilungen für klinische Chemie mit anderen diagnostischen Basis-
fächern, z. B. Mikrobiologie, Cytologie, Nuklearmedizin usw. in Departments für Laboratoriumsmedizin zu integrie-
ren. Nicht nur das interdisziplinäre Verständnis, sondern auch die Kooperation könnte dadurch entscheidend ver-
bessert werden.
Hinsichtlich der Fprschungsaktivitäten scheint es an der Zeit, sich vermehrt Fragen der klinischen Medizin, aber auch
der reinen und angewandten und biologischen Forschung zu widmen.
*) Revised from a paper given by the author at the 22nd. annual meeting of the,Swiss Society for Clinical Chemistry, 9- 10th. of June,
1978, at Aarau.
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Introduction
A report on the future of Clinical Chemistry presents
certain difficulties, due to the fact that the terms
"Clinical Chemistry" and "Clinical Biochemistry" are
interpreted in very different ways by different people.
A very early indication to the existence of Clinical
Chemistry was given by Shakespeare in the Merchant
of Venice "... My blood speaks to you in my veins . .."
and our discipline is increasingly learning how to
listen. (1)
More recently, less poetic definitions have been given
by other authors (2-8).
All definitions agree to the point, that the most impor-
tant function of our discipline is to support medical
diagnosis and control of therapy by chemical analyses.
Ideas differ strongly, however, as to whether Qinicäl
Chemistry should encompass other classic "disciplines"
and which these might be.
Does Clinical Chemistry pertain to all chemical aspects
of human life in health and disease? And does Clinical
Chemistry include the explanation of the nature and
etiology of diseases, too? Should we make contributions
in the field of Clinical Pharmacology, Preventive
Medicine and Toxicology?
The definition of Richterich in the first edition (9) of
his textbook said, that ".. . Clinical Chemistry is that
medical branch dealing with the development and
application of chemical analysis for diagnostic pur-
poses ...".
In the last edition (10) it is defined as follows ".. .
Clinical Chemistry is that branch of medicine dealing
with development and application of chemical analyses
of body fluids and other biological materials for
diagnosis, therapy and prophylaxis of diseases .. .".
The much broader range of Clinical Chemistry in these
definitions is significant.
In the following, I will discuss which definition seems
to be the most acceptable for the future, as the role
of clinical chemist evolves and new tasks present them-
selves.
In order to make an extrapolation of the discipline
"Clinical Chemistry and Clinical Biochemistry" for
the next ten years and in order to get a practicable
scheme, I will divide the theme into 6 categories.
1. General trends of development of methods
and instruments
In the routine analytic field I believe that photometric
methods will continue to predominate in the years to
come for the determination of substrates and enzyme
activities. For substrates, specific enzymatic reactions
will increasingly replace the older, less specific colour
tests. This is urgently required for creatinine and
phosphate in serum. In the field of bile pigments,
especially bilirubin and bilirubinoids, the situation is
frustrating. Probably, kinetic methods will replace
more and more the end-point tests. This tendency
will also prevail in the field of enzymology. Here we
can expect new methods for the determination of
-amylase, acid phosphatase, lipase and some other
enzymes.
Immunological methods are becoming increasingly
important in the routine analytical work. In addition
to radial immunodiffusion, the nephelometric
techniques are also developing, as evidenced by the
introduction of laser-nephelometers. In the radio-
immunoassay 12SI is used as a label in preference to
3H and 14C, owing to the short measurement times
and the non^specialised character of the scintillators.
To what extent enzyme-immunoassays and fluorescence
immunoassays will substitute the radio-immiinoassays
is a matter of economics and legislation: the more
liberal the laws of radiation, the better the prospects
for the radio-immunoassays and vice versa.
It is not possible to predict how long the protein electro-
phoresis will keep its position despite its doubtful
diagnostic relevance. The proposal ofLaurell (11) to
use the electropherograms only in a qualitative way,
in order to decide which, if any individual protein
should be quantitatively determined, has not yet been
realized in most laboratories.
Newly designed photometers will be smaller than
before and the volume of the measuring solution will be
reduced. Thanks to the microprocessor we can expect
that in a few years each photometer will be equipped
with a so-called intelligent terminal.
In photometry, higher resolving power will be possible,
as well as better compensation of stray-light-effects.
The optimum light source would be a tunable laser but
progress on this field seems to be relatively slow. ·
Also, the flame photometer will be equipped with
intelligent terminals. It is surprising that in this field we
do not recognise a trend for miniaturization. The
development of a flame photometer without a flame
or without the unwieldy gas flasks would be desirable.
At present, it seems that we need further flame photo-
metry for the determination of group 1A elements of
the periodic table.
Ion specific electrodes are still being developed, but not
as fast as we assumed ten years ago. The long lag-phases,
the possibilities of drifting and the multiplicity of inter-
ferences are the reasons why ion specific electrodes are
relatively seldom used for routine analysis. Similar
problems plague enzyme electrodes.
In the near future some tests will become fast, highly
specific and very economic by the exploitation of the
modern techniques of immobilized enzymes.
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It seems not very probable that atomic absorption
spectrometric methods will expand in the next future.
The same is also true for fluorometric techniques.
It is also uncertain as to when the stix techniques will
revolutionize our laboratories. It is evident, that very
early publication of the Kodak developments may have
been untimely, because nobody is able to assess the
consequences of these techniques for the future.
2. Newer aspects of mechanisation and automation
In the field of mechanisation and automation it seems
certain that the continuous flow systems will keep an
important place in our laboratories. Three tendencies
are significant: The analyzer will become faster, more
economical with respect to sample and reagent volume,
and the system control will be performed by micro-
processors or minicomputers.
Similar developments may be expected with the fast
analyzers with rotors.
The situation is unclear for all the other analyzers which
are working in a discrete but indiscriminating manner.
For longer sample series we may continue with batch-
wise processing. But with respect to the future, I forecast
that analyzers which work in a discrete and discriminat-
ing manner will be more favored. Examples of this kind
of analyzer are the GSA2) of Greiner, Du Font's ACA,
the STAC from Technicon and the PRISMA from LKB.
All these analyzers have one handicap, i. e. the low
cost/efficiency ratio: Some need relatively high volumes
of sample and reagents, some have relatively high costs
for implementation, or for operating, or for both.
Most laboratories fulfil more than 90% of their daily
routine task with only 20 different tests. Therefore we
need a 20 channel analyzer, which is able to perform
these 20 tests identically for each sample in a discrete
and discriminating fashion.
For the measurement of radioactivity we are using
today mostly partially mechanized systems. New
developments for longer series are basing on the
" walk-awäy-äutomation".
3. Uncertainities and chances of unusual, unconventional
and of new methods
Another question is, whether methods and instruments,
now in.use only for research arid development by
2) ACA: Automatic Clinical Analyzer, Firma du Pont de
Nemours, Wilmington, USA
EDP: Electronic Data SProcessing
GSA: Greiner Selective Analyzer, Firma Greiner, Langen-
thal, Switzerland
OCR: Optical Character Recognition
PRISMA: Programmable Individual Selective Modular Ana-
lyzer Firma Clinicon, Mannheim, Federal Republic
of Germany
STAC: Single Test Analyzer with Computer, Firma
Technicon, Inc. Tarrytown, USA
laboratories with high standards, could have a broader
spectrum of application in the future?
Chromatographie methods e. g. thin layer chromato-
graphy, affinity chromatography, gas chromatography
in connection with mass spectrometry, and other
techniques will be reserved for the larger laboratories.
But there are two sophisticated techniques which have
great potential. First of all I would mention thermo-
metry for the measurement of enthalpy of chemical
reactions. The reason for this interest is the high
universality of applications of enthalpimetric techniques.
Already they are installed in continuous flow systems
for control purposes of technical process. With thermo-
sensors it is also possible to control enzyme catalyzed
reactions. E. g. a system has been just published for
measuring the hexokinase reaction by its enthalpy (12).
The combination of immobilized enzymes with thermo-
metric techniques for the quick determination of sub-
strates, such as urea, or uric acid and others could be
especially fruitful.
This kind of monitoring can also be used for immuno-
logical reactions. Certain difficulties still prevent a
broader application, but I can imagine that these
problems of instrumentation can be solved. Then it
could happen — especially in mechanized systems —
that measurement of enthalpy will replace photo-
metry for a number of analytical methods.
A second and also very interesting field could be the
development of methods basing on bioluminescence
or chemoluminescence. The extreme sensitivity and
the wide range of applications of these types of
methods is most impressive. ATP and NAD coupled
reactions can be monitored in this way. Also, enzyme
activities in the cells, or inside of microorganisms, can
be measured using these techniques. Click has published
a very interesting paper about the methods and has
made claims that allow for great expectations (13).
4. Evolution of organizational aspects
Most of the larger laboratories support their laboratory
operations with an EDP system. The better cost/
efficiency ratio in this field will be the reason why
computers will further infiltrate medical laboratories.
Instrumentation and the volume of test-programs are
decisive for all sample distribution processes.
No method so far for the mechanisation of sample
distribution has been completely successful. Some
manufacturers have cancelled the development or the
production of these systems. It seems that manual
processing is superior to the mechanical systems in
this area. The centralized sample distribution needs a
system for identification. Today mark-sense-cards or
bar-code labels are most important. A new, very interest-
ing technique is the OCR-reading. Its special advantage
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is that the OCR-code can be read electronically as well
as visually and that it can be written by any type of
typewriter. As soon as certain technical difficulties are
solved, we can expect that this method of identification
will be used by many laboratories.
The discussion about on-line versus off-line connections
of instruments to the computer has ceased. The big
computer is replaced by many small minicomputers
and the intellegent terminals are taking charge of all
data pre-processing. Unsolved sofar is the problem of
data transport or data-transfer from the laboratory to
the ward or the external physician. Also many problems
of data storage with fast memory access (important for
the laboratory information) remain open, as long as
economic limitations exist. We are awaiting new
developments in the field of mass memories with better
economic aspects.
5. Necessities for standardization
Many important problems should be solved in the field
of standardization. I would like to raise again the
question: which temperature should be used for the
determinations of enzyme activities? It is unquestionable
that the use of different temperatures in different
geographical regions represents a very unsatisfactory
situation. Everybody has agreed that optimized methods
are preferable, but what are optimized methods?
The quality control is more important and should
receive more widespread attention than it does today.
The reference materials are inadequate for many
problems, especially in the field of immunological
tests.
Furthermore we should make more effort in the
standardization of terminology, in order to get world-
wide consensus.
Precise descriptions and the comparison of methods
are not only not standardized, but they are also
neglected. In most cases it is not possible to get a
clear picture of a method from a publication in one
of our journals. However this would be required in order
to decide whether a new method should be introduced
or a conventional method replaced. For many decades
we have had to try each new interesting test in our
own laboratory, compare it with present tests, and
then decide by ourselves what to do. Standards and
definitions for descriptions of methods on an internatio-
nal level would be very useful.
6. State of Clinical Chemistry, identity as a research
and academic discipline
The situation of Clinical Chemistry in general and
academic hospitals, in public and private laboratories is
indeed impressive: A great variety of an ever increasing
number of tests are available around the clock for
diagnosis and for control of therapy. Skilled technicians
are working in big laboratories. Expensive instruments,
analyzers and machines for electronic data processing
are in use. The budget of Clinical Chemistry departments
is often much higher than that of other institutions
such as pathology or microbiology. But does this all
correspond to the importance of clinical chemistry as
a medical speciality and as an academic discipline?
A certain amount of doubt seems appropriate: The
widespread image of the laboratory wrestling with a
constantly increasing number of specimens and tests
and the nervous hustling and shuffling of request cards
into result sheets has not augmented the reputation of
our discipline. Moreover, the prestige of the discipline
did not improve when industry began to introduce pre-
prepared reagents. With these testkits, unskilled
personel are also able to maintain a satisfactory quality
of analytical performance!
The use of the big analyzers has led in many places to
a methodological conservatism. Newly developed
methods with higher specifity are not introduced,
either because the changing of the analyzer is difficult,
or because industry does not manufacture a so-called
"pack for automation" for this new method. Being
afraid of a disruption of the production of results of
the day, quantity is prefered over quality. The so-called
automation (in fact rather more a mechanisation) has
solved problems of quantity, but has created new
problems of quality. It is not surprising that certain
clinical chemistry departments seem to resemble an
industrial factory, where the incoming orders are
worked up as quickly and as cheeply as possible. The
product of this factory is ä result sheet, the single link
to the costumer. Contact with him is only accepted in
case of complaints.
Research
The research activities of many laboratories are limited
to questions of methodology and work processes. Evalua-
tions of new instruments and new reagentracks of
industry take up a large place in our scientific journals.
But this particular topic is not of any interest to our
clinical colleagues. Many of them are no longer interested
in the progress of Clinical Chemistry in contrast to other
diagnostic disciplines. The inability of clinicians to master
the development of our discipline will lead to the
apostrophe, referring to the Clinical Chemist, as the
"little chemist, unable to make essential contributions
to medical research". This unfriendly sentence referred
to by Astrup (4) in Toronto might overstate the case,
but it contains some truth, not only in Scandinavia.
Development
For a promising and fruitful development of the
discipline of Clinical Chemistry it is necessary to
reorient the goals: Toward the clinical problems on the
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one hand and to pure and applied biological research
on the other.
Clinical problems
With respect to clinical problems immediately con-
cerning our discipline I would like to give some actual
examples:
Without any doubt the analytical accuracy and precision
of many methods are satisfactory for the clinical
questions. Another question pertains to the diagnostic
validity. And this question, which is much more impor-
tant, is not systematically or sufficiently examined.
Papers in this field are published mainly by Scandinavian
and US authors. The well known book of Galen &
Gambino (14) "Beyond normality" has had a world
wide succes and has stimulated a great interest in the
methods for calculating the diagnostic value of a
laboratory test. These methods are based on the Bayes
Theorem, Shannon's information theory, statistical
decision techniques, especially the discriminant analysis,
multivariate analysis and factor analysis. These methods
should also become tools of the modern clinical chemist.
However, the goal should not only be the production
and transfer of numbers; the critical evaluation and
interpretation also comes within our scope. Interpreta-
tion with respect to the dynamic steady states, the
circadian and intraindividual rhythms, the actual status
of the disease and its treatment: these all are challenges
to the clinical chemist. In this connection we necessarily
need very close cooperation with our clinical colleagues
of all departments.
Thus borderlines of the disciplines are crossed and an
interdisciplinary dialogue will have to take place. These
contacts need to be established not only with specialist
doctors, but also with the toxicological laboratories of
industry, preventive medicine and others.
In the field of control of drug effects and side effects
we could cooperate with clinical pharmacology. The
good contact with the hematological departments
should be extended also to histology, cytology and
other morphological disciplines.
Biological research
Morover the clinical chemist should be more active in
the field of pure and applied biological research: cells
and cell cultures are new and very important materials
for our laboratories. The diagnostic use of tissue cultures
might be a new avenue for analysis. The sensitivity of
malignant cells to certain chemical compounds could
be investigated in our laboratories. A beginning has
been made by the estrogen and gestagen receptors. This
technique is of a great interest to all clinical chemical
laboratories and should be intensively cultivated in the
near future.
Another field recently discovered by Clinical Chemistry
is coagulation research. With the newly developed, so-
called chromogenic substrates we could make a sub-
stantial contribution to research and diagnosis in the
field of coagulopathias. But clearly, the number of inter-
ested clinical chemist is very small so far.
Conclusions
It seems that the future of clinical chemistry is not
dependent on faster and faster automatic machines:
neither is it dependent on simpler and simpler test kits,
or on an ever increasing number of tests. It depends on
our own attitude to our discipline. If our clinical
colleagues qualify clinical chemistry as a pure technical
speciality and if we accept this qualification, then we
will be, in the future, no more than paramedical
technicians.
One of the arguments against the postulated expansion
of our discipline might be that medical research is
extremely expensive today. But exactly this point is an
argument for our case: The clinical chemists have at
their disposal a great wealth of knowledge in the basic
sciences. They have great technological experience,
well qualified personnel available and very expensive
instrumentation. The same is true in many places for
the other diagnostic disciplines e. g. hematology, cytology
and microbiology.
The clear separation of these disciplines into independent
kingdoms, as is usual in Central Europe, prevents the
utilization of all technical and intellectual potentials.
In many US and Scandinavian hospitals these disciplines
are united within one "Department for Laboratory
Medicine". And these departments of laboratory
medicine are more open and more available for co-
operation with the clinicians. Through the common
use of many installations like mechanical shops, library,
electronic data processing units and so on, the overall
cost can be decreased. And the close cooperation of
all diagnostic disciplines with all clinical departments
will lead to a better understanding of all concerned
with patient health care.
Whatever we intend and whatever we do, the future is
dependent on our own philosophy, and on our own
ability to master more challenging problems.
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